Lactobacillus plantarum CN2018

20+ granted patents and proprietary strains from CCFM, CN and DSM collections — clinically studied and available for exclusive licensing.

Lactobacillus plantarum CN2018

Key Benefits

• Inhibits Helicobacter pylori growth
• Reduces H. pylori urease activity
• Decreases H. pylori colonization in the stomach
• Prevents gastric tissue pathological changes

Key Data

• Survives in pH 2.5 simulated gastric juice and 0.2% bile salt medium – ensures high activity in the host gut
• In animal models (H. pylori‑infected mice): significantly lowers H. pylori load in gastric tissue; reduces anti‑H. pylori IgG antibody levels; protects against gastric mucosal damage (histopathology confirmed)

Why Choose CN2018?

  • Specifically developed to combat H. pylori – a major cause of chronic gastritis and gastric ulcers

  • Superior survival in harsh gastric conditions ensures delivery of viable cells to the target site

  • Proven in animal models to both reduce bacterial load and protect gastric tissue, offering dual benefits for functional foods targeting digestive wellness

  • Ideal for supplements aimed at upper digestive tract health, especially for consumers with recurring H. pylori issues